{"abstract": "Companies like Allergan, Valeant, Salix, Actavis and Medtronic are riding a wave of cheap debt and pent-up demand in a slew of recent acquisitions or attempted acquisitions.", "web_url": "https://dealbook.nytimes.com/2014/10/03/a-scramble-to-acquire-for-drug-companies/", "snippet": "Companies like Allergan, Valeant, Salix, Actavis and Medtronic are riding a wave of cheap debt and pent-up demand in a slew of recent acquisitions or attempted acquisitions.", "lead_paragraph": "A chain reaction of deal-making and acquisition talks is continuing to reshape the pharmaceutical industry, with a handful of big companies jostling to outmaneuver their competitors.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/04/business/04drug-jp/04drug-jp-articleLarge-v2.jpg", "height": 399, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/10/04/business/04drug-jp/04drug-jp-articleLarge-v2.jpg", "xlargewidth": 600, "xlargeheight": 399}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/04/business/04drug-jp/04drug-jp-jumbo-v2.jpg", "height": 682, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/04/business/04drug-jp/04drug-jp-superJumbo-v2.jpg", "height": 1363, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/04/business/04drug-jp/04drug-jp-thumbStandard-v2.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/10/04/business/04drug-jp/04drug-jp-thumbStandard-v2.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/04/business/04drug-jp/04drug-jp-thumbLarge-v2.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "A Scramble to Acquire for Drug Companies", "kicker": "DealBook", "content_kicker": null, "print_headline": "A Scramble to Acquire for Drug Companies", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Covidien plc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Medtronic Inc", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 8, "major": "N"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "rank": 9, "major": "N"}], "pub_date": "2014-10-04T01:23:52+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/04e4e168-9d4b-5331-93ea-3d30f5dda513", "word_count": 845, "uri": "nyt://article/04e4e168-9d4b-5331-93ea-3d30f5dda513"}